Showing results (611-620 of 749) with videos related to

Sort By:
Pageof 75
BMC Medical Genomics|October 27, 2021
Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuseVanessa Troiani, Richard C Crist, Glenn A Doyle, et al.
BMC Cancer|November 20, 2024
Classification of pediatric soft and bone sarcomas using DNA methylation-based profilingFelipe Luz Torres Silva, Mayara Ferreira Euzébio, Juliana Silveira Ruas, et al.
Critical Reviews in Oncology/Hematology|October 23, 2024
Endometrial cancer in the elderly: Characteristics, prognostic and risk factors, and treatment optionsMiriam Forte, Sabrina Chiara Cecere, Marilena Di Napoli, et al.
Frontiers in Bioscience (Landmark Edition)|August 30, 2022
Sphingomyelin in Human Breast Milk might be Essential for the Hippocampus MaturationElisabetta Albi, Cataldo Arcuri, Toshihide Kobayashi, et al.
Cancers|December 17, 2024
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim AnalysisFrancesca Consoli, Marco Tucci, Jacopo Pigozzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 13, 2018
Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor ModelsCarminia Maria Della Corte, Vincenza Ciaramella, Claudia Cardone, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 30, 2019
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell linesPietro Paolo Vitiello, Claudia Cardone, Giulia Martini, et al.
Cancers|April 13, 2023
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical TrialsDavide Ciardiello, Stefania Napolitano, Vincenzo Famiglietti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2015
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung CancerCarminia Maria Della Corte, Claudio Bellevicine, Giovanni Vicidomini, et al.
ESMO Open|October 12, 2017
Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programmeVincenzo Sforza, Erika Martinelli, Claudia Cardone, et al.
Pageof 75